| http://dbpedia.org/ontology/abstract
|
Adagrasib (INN, codenamed MRTX-849), is an … Adagrasib (INN, codenamed MRTX-849), is an experimental cancer drug being developed by Mirati Therapeutics. It acts as a covalently binding inhibitor for a mutant form of the protein KRAS called G12C, which is commonly present in various forms of cancer and acts as a growth factor. It has shown promising results in pre-clinical testing and is currently in clinical trials.sting and is currently in clinical trials.
|
| http://dbpedia.org/ontology/casNumber
|
2326521-71-3
|
| http://dbpedia.org/ontology/drugbank
|
DB15568
|
| http://dbpedia.org/ontology/fdaUniiCode
|
8EOO6HQF8Y
|
| http://dbpedia.org/ontology/kegg
|
D12301
|
| http://dbpedia.org/ontology/pubchem
|
138611145
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Adagrasib.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
67027951
|
| http://dbpedia.org/ontology/wikiPageLength
|
5376
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1116636629
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Sotorasib +
, http://dbpedia.org/resource/KRAS +
, http://dbpedia.org/resource/Mirati_Therapeutics +
, http://dbpedia.org/resource/International_Nonproprietary_Name +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Growth_factor +
, http://dbpedia.org/resource/Investigational_new_drug +
, http://dbpedia.org/resource/Category:Piperazines +
, http://dbpedia.org/resource/Category:Experimental_cancer_drugs +
|
| http://dbpedia.org/property/atcPrefix
|
None
|
| http://dbpedia.org/property/c
|
32
|
| http://dbpedia.org/property/casNumber
|
2326521
|
| http://dbpedia.org/property/cl
|
1
|
| http://dbpedia.org/property/drugbank
|
DB15568
|
| http://dbpedia.org/property/f
|
1
|
| http://dbpedia.org/property/h
|
35
|
| http://dbpedia.org/property/iupacName
|
{-4-[7--2-{[-1methylpyrrolidin-2-yl]methoxy}-5,6,7,8tetrahydropyrido[3,4-d]pyrimidin-4-yl]-1-piperazin-2-yl}acetonitrile
|
| http://dbpedia.org/property/kegg
|
D12301
|
| http://dbpedia.org/property/legalStatus
|
http://dbpedia.org/resource/Investigational_new_drug +
|
| http://dbpedia.org/property/n
|
7
|
| http://dbpedia.org/property/o
|
2
|
| http://dbpedia.org/property/pubchem
|
138611145
|
| http://dbpedia.org/property/smiles
|
CN1CCC[C@H]1COC2=NC3=CCN6CCNCCF
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
PEMUGDMSUDYLHU-ZEQRLZLVSA-N
|
| http://dbpedia.org/property/unii
|
8
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_drug +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Fdacite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Experimental_cancer_drugs +
, http://dbpedia.org/resource/Category:Piperazines +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Adagrasib?oldid=1116636629&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Adagrasib.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Adagrasib +
|
| owl:sameAs |
http://dbpedia.org/resource/Adagrasib +
, https://global.dbpedia.org/id/FoER8 +
, http://www.wikidata.org/entity/Q105816120 +
|
| rdf:type |
http://dbpedia.org/ontology/Drug +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
|
| rdfs:comment |
Adagrasib (INN, codenamed MRTX-849), is an … Adagrasib (INN, codenamed MRTX-849), is an experimental cancer drug being developed by Mirati Therapeutics. It acts as a covalently binding inhibitor for a mutant form of the protein KRAS called G12C, which is commonly present in various forms of cancer and acts as a growth factor. It has shown promising results in pre-clinical testing and is currently in clinical trials.sting and is currently in clinical trials.
|
| rdfs:label |
Adagrasib
|
